Save information for later
Sign Up

Learn About Angiosarcoma of the Liver

View Main Condition: Angiosarcoma

What is the definition of Angiosarcoma of the Liver?
A malignant vascular neoplasm arising from the liver.
What are the alternative names for Angiosarcoma of the Liver?
  • Angiosarcoma of the liver
Who are the top Angiosarcoma of the Liver Local Doctors?
Elite in Angiosarcoma of the Liver
Elite in Angiosarcoma of the Liver
Kantonsspital St. Gallen, 
Sankt Gallen, SG, CH 

David Semela practices in Sankt Gallen, Switzerland. Mr. Semela and is rated as an Elite expert by MediFind in the treatment of Angiosarcoma of the Liver. His top areas of expertise are Angiosarcoma of the Liver, Angiosarcoma, Hepatitis C, Hepatitis, and Liver Transplant.

Elite in Angiosarcoma of the Liver
Elite in Angiosarcoma of the Liver

University Of Louisville Physicians Inc

401 E Chestnut St, Suite 310, 
Louisville, KY 
Languages Spoken:
English
Accepting New Patients

Matthew Cave is a Hepatologist in Louisville, Kentucky. Dr. Cave and is rated as an Elite provider by MediFind in the treatment of Angiosarcoma of the Liver. His top areas of expertise are Non-Alcoholic Fatty Liver Disease, Angiosarcoma of the Liver, Alcoholic Cirrhosis, Cirrhosis, and Endoscopy. Dr. Cave is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Advanced in Angiosarcoma of the Liver
Advanced in Angiosarcoma of the Liver

Memorial Solid Tumor Group

160 E 53rd St, 
New York, NY 
Languages Spoken:
English
Offers Telehealth

Sandra Dangelo is an Oncologist in New York, New York. Dr. Dangelo and is rated as an Advanced provider by MediFind in the treatment of Angiosarcoma of the Liver. Her top areas of expertise are Adult Soft Tissue Sarcoma, Merkel Cell Carcinoma, Synovial Sarcoma, Liposarcoma, and Liver Embolization.

What are the latest Angiosarcoma of the Liver Clinical Trials?
A Phase 1, Open-Label, Dose-Escalation and Expansion Study of AGX101, a TM4SF1 Directed Antibody Drug Conjugate in Patients With Unresectable, Locally Advanced, or Metastatic Solid Tumors

Summary: AGX101 is an antibody-drug conjugate (ADC) therapy for tumor-forming cancers. The purpose of this study is to learn about AGX101 effects and safety at various dose levels in an all-comers advanced solid cancer patient population. AGX101will be administered intravenously. Dosing of AGX101 will be repeated once every 3, 6 or 9 weeks. Participants may continue study treatment until disease progressio...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A French Multicenter Observational Retrospective Study of Rare Primary Liver Cancers

Summary: The aim of this French multicenter retrospective study is to describ rare primary hepatic cancers clinical, histological and radiological features, to obtain a biological tumor and blood collection, and to evaluate the efficacy of treatments received in clinical practice in order to determine optimal therapeutic sequences. This retrospective cohort will be the backbone of future translational stud...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center